We are investing actively in research to strengthen the scientific foundation of the platform. Azento Health has initiated multiple research projects, including in vitro and in vivo work, large clinical trials and real-world evidence programs (RWE) with Forte80®. These projects are designed to build deeper understanding of how microbiome-based companion support can fit into the evolving landscape of obesity care and Modern Obesity Treatments.
Obesity treatment is not one single moment. It is a journey. Patients may need support before treatment starts, during dose escalation, through active weight loss, during long-term treatment, and after treatment interruption or discontinuation.
That is why Azento Health is building a pipeline of 10+ products and concepts across the full patient journey – both under our own brand and through partner-developed, unbranded solutions.
Our ambition is to become a leading microbiome-based companion platform for modern obesity care.